Cite
HARVARD Citation
Domingo, E. et al. (2018). Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series. Lancet gastroenterology and hepatology. pp. 635-643. [Online].